Bacterial isolates, antibiotic susceptibility, and determinants of positive blood culture in children with community-acquired pneumonia in Central Tanzania
Rehema Tagalile, Fransisca Kimaro, Emmanuel Nkuwi, Dina Mahamba
Corresponding author: Dina Mahamba, Department of Paediatrics and Child Health, School of Medicine and Dentistry, The University of Dodoma, Dodoma, Tanzania 
Received: 04 Feb 2025 - Accepted: 30 Aug 2025 - Published: 05 Dec 2025
Domain: Bacteriology,Microbiology,Pharmacology
Keywords: Bacteremia, community-acquired, pneumonia, children, antibiotic, predictors
Funding: This work received no specific grant from any funding agency in the public, commercial, or non-profit sectors.
©Rehema Tagalile et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Rehema Tagalile et al. Bacterial isolates, antibiotic susceptibility, and determinants of positive blood culture in children with community-acquired pneumonia in Central Tanzania. Pan African Medical Journal. 2025;52:145. [doi: 10.11604/pamj.2025.52.145.46769]
Available online at: https://www.panafrican-med-journal.com//content/article/52/145/full
Research 
Bacterial isolates, antibiotic susceptibility, and determinants of positive blood culture in children with community-acquired pneumonia in Central Tanzania
Bacterial isolates, antibiotic susceptibility, and determinants of positive blood culture in children with community-acquired pneumonia in Central Tanzania
Rehema Tagalile1, Fransisca Kimaro2, Emmanuel Nkuwi3,
Dina Mahamba4,&
&Corresponding author
Introduction: despite the widespread coverage of haemophilus influenzae type b (Hib) and pneumococcal conjugate vaccines, the mortality of children under five years due to community-acquired pneumonia (CAP) in Tanzania remains unacceptably high. This study aimed to identify bacterial isolates, antibiotic susceptibility, and factors associated with blood culture positivity in children under five with CAP.
Methods: a cross-sectional study involving 195 children under-five years of age who were clinically diagnosed with CAP was conducted at a referral hospital in central Tanzania from October 2018 to March 2019. Blood samples were taken, identification of culture isolates was performed through conventional bacteriological methods, followed by antibiotic susceptibility testing. Demographic and other data were collected using a standardized tool.
Results: bacteremia was prevalent in 7.2% of participants, with Staphylococcus aureus being the most common isolate (57.1%). Overall, isolates were less sensitive to the WHO first-line antibiotics recommended for CAP treatment (penicillin and cephalosporins) but were sensitive to ciprofloxacin and clindamycin. Fever (>38.5°C), oxygen saturation (<90%), the need for oxygen therapy, a high respiratory rate (>60 cycles/minute), and leucocytosis (>15,000 cells/μl) were independent factors associated with positive blood culture.
Conclusion: bacteraemia in children with CAP was nearly than 10%, predicted by high respiratory rates, hypoxia, fever, and leucocytosis. Most of the isolates were insensitive to antimicrobials listed in the WHO-recommended first-line treatment for CAP, outlining the importance of routine culture and antimicrobial susceptibility.
Community-acquired pneumonia (CAP) refers to a lower respiratory tract infection occurring in a person who has not resided in a hospital or health care facility in the preceding 14 days [1]. Overall, CAP accounts for a significant proportion of childhood pneumonia cases, causing morbidity and mortality in developing countries and globally [2-4]. Despite efforts to prevent CAP, including widespread vaccination, Tanzania remains among the low- and middle-income countries (LMICs) with the highest number of CAP-related deaths [5,6]. The persistence of CAP cases is likely due to pathogens not covered by the Pneumococcal Conjugated Vaccine (PCV) and Haemophilus influenza type b (Hib) vaccine.
Measures to prevent and treat CAP in children face multiple challenges, including accurate clinical diagnosis and determination of etiology [7]. The symptoms of CAP differ by age and can be nonspecific in pediatric patients, with causative agents often varying based on age and geographical region. Overall, viruses account for more than 50% of CAP cases in children under five years, particularly during the first two years of life [3]. Streptococcus pneumoniae is the most common bacterial cause, followed by Haemophilus influenzae, Streptococcus pyogenes, Staphylococcus aureus, Moraxella catarrhalis, Mycoplasma pneumoniae, Chlamydia trachomatis, and Ureaplasma urealyticum. On several occasions, these pathogens have shown reduced sensitivity to amoxicillin and cephalosporin, and the WHO recommended first-line antibiotics for CAP treatment [7,8].
Despite CAP being the most important cause of morbidity among children under five in the developing world, bacterial isolates, antibiotic susceptibility, and factors associated with positive blood cultures have not been adequately studied, especially in the context of expanded vaccine coverage. This has resulted in undocumented patterns of etiology, a lack of evidence-based prevention strategies, and the irrational use of antibiotics, thereby exacerbating the global burden of antimicrobial resistance. This study was therefore conducted to determine the bacterial isolates, antibiotic susceptibility, and factors associated with positive blood cultures among children with CAP in central Tanzania.
Study design, setting, and participants: we conducted a hospital-based cross-sectional analytical study from October 2018 to March 2019 at Dodoma Regional Referral Hospital (DRRH) in central Tanzania. Dodoma Regional Referral Hospital (DRRH) is an affiliated teaching hospital for the University of Dodoma with 434 bed capacity of total, including 54 beds for paediatric patients. Approximately 300 paediatric patients are admitted per month. The study enrolled all children aged 2 to 59 months who were admitted with signs and symptoms of CAP, provided that their parents or guardians had signed written informed consent. The minimum sample size of 195 children was calculated using the Leslie Kish formula, based on an 8% prevalence of bacteraemia among children with CAP reported by Sigauque et al. [9], with a 5% margin of error and 95% confidence interval. Children with a history of foreign body aspiration, chemical ingestion, and who had a history of hospital visits or admissions within the past two weeks were excluded. Children meeting eligibility criteria were conveniently sampled until the minimum sample size was attained.
Data collection methods and tools: a structured questionnaire was used to collect sociodemographic data of both children and parents or guardians (age, sex, marital status, education level, occupation, family history of smoking, and size of family). Additionally, clinical information on the children, such as cough, difficulty breathing, runny nose, fever, nutritional status, and vaccination status, was collected.
In particular, information on receiving Pneumococcal conjugate and Haemophilus influenzae type b vaccines was gathered from the Reproductive and Child Health (RCH) card. A thorough physical examination was then performed while looking for signs of CAP and nutritional status, followed by blood sample collection for culture and sensitivity testing. All the children were managed according to the respective standard hospital guidelines [9]. Operationally, we defined CAP as cough and/or difficulty in breathing and any of the added symptoms, including increased respiratory rate, respiratory distress (grunting, head nodding, lower chest wall indrawing), and oxygen saturation <90% in room air to a child for a child who had no history of hospital visit or admission within past two weeks before current admission [7]. Malnutrition was diagnosed based on WHO growth standards, defined as mid-upper arm circumference (MUAC) < 11.5 cm in children aged 6 months and above, or weight-for-height/length Z-score <-2 standard deviations (SD), and/or the presence of bilateral pitting edema [10].
Laboratory procedures: for blood culture and sensitivity testing, 3 mL of venous blood was aseptically drawn prior to the initiation of antibiotic therapy, following sterilization of the puncture site with 70% isopropyl alcohol. The drawn blood was then inoculated directly into blood culture bottles (BD Bactec Peds Plus, Mississauga, Canada), which were incubated in an automated blood culture machine (BD Bactec 9050, Illinois, USA). Blood samples were incubated and periodically monitored for turbidity. The drawn blood was then inoculated directly into blood culture bottles (BD Bactec Peds Plus, Mississauga, Canada), which were incubated in an automated blood culture machine (BD Bactec 9050, Illinois, USA). Blood samples were incubated and periodically monitored for turbidity.
Positive blood culture samples were Gram-stained and subcultured on 5% CO2 blood, MacConkey, and chocolate agar plates. The bacterial isolates were identified using conventional biochemical tests, and antibiotic sensitivity testing was performed using the disc diffusion method in accordance with the Clinical Laboratory Standard Institute (CLSI) guidelines [11]. The antibiotics used for susceptibility testing were ampicillin, chloramphenicol, ceftriaxone, ciprofloxacin, gentamicin, erythromycin, clindamycin, cefuroxime, and penicillin. Staphylococcus aureus (ATC 25923) and Escherichia coli (ATCC 25922) strains were used to ensure quality control.
Data analysis: binary logistic regression was used to identify factors independently associated with positive blood culture results (outcome: positive versus negative). Variables with p<0.0.5 in univariate analysis were included in the multivariate model to adjust for confounders. Independent variables assessed included age, sex, nutritional status, fever, hypoxia, prior antibiotic use, existing chronic disease, oxygen saturation during admission, and white blood cell count. Results are reported as odds ratios (ORs) with 95% confidence intervals (CIs), and p<0.05 was considered significant. Analyses were performed using SPSS version 25.
Ethics approval and consent to participate: ethical clearance was sought from the University of Dodoma research ethics and scientific review committee (reference number UDOM/DRP/134 VOL VI/66-14). Permission to conduct the study was obtained from the Dodoma Regional Referral Hospital authorities. Informed consent was obtained from all parents and guardians who agreed that their children would participate.
Study participants enrolment: during the study duration, a total of 1,517 children were admitted to DRRH. CAP was clinically diagnosed among 14.3% (217) of participants, from which 195 children passed the eligibility criteria for the study (Figure 1).
Sociodemographic characteristics of the enrolled children and their parents or guardians: a total of 195 children were clinically diagnosed with CAP and enrolled in this study. The study participants had a mean age of 14.65± SD months, with the majority (62%) being males (Table 1). Of note, most parents or guardians (70.3%) had a primary school education, and 13.8% reported having a family member who smoked cigarettes. Additionally, nearly forty percent (39.5%) of the children had a history of antibiotic use for an average of two (2) days within the previous 14 days (Table 1).
Nutritional and vaccination status of children with CAP: among all the children enrolled, 6.7% (13/195) were severely malnourished, followed by 5.6% (11/195) who were moderately malnourished. On the other hand, 85.6% (167/195) were completely immunized while, whereas 11.3% (24/195) were partially immunized (had only up to 2 vaccine doses), and 3.1% (6/195) were not immunized. In particular, the majority (96.9%, 189/195) of the children had received at least a single dose of Pneumococcal Conjugated Vaccine (PCV) and Haemophilus influenzae type B (HiB) vaccine (Figure 2).
Clinical characteristics of children with CAP: cough was the most common clinical presentation observed in all the children (100%), followed by difficulty in breathing, which was noted in 93.8% (183/195) of the participants (Figure 3). Slightly more than half of the children presented symptoms such as a running nose, crackles, nasal flares, hypoxia, and lower chest wall indrawing. Fever was present in a quarter of the participants, whereas wheezing was observed in only 9.2% of all children with a CAP diagnosis (Figure 3). None of the children presented with signs of complicated pneumonia, and no participant required ICU admission or intubation during the study period.
Prevalence and distribution of bacterial isolates from positive blood cultures: among the 195 children diagnosed with CAP, 7.2% (14/195) had positive blood cultures (Figure 4A). Staphylococcus aureus was the most frequently isolated pathogen, accounting for 57.1% (8/14) of the positive cultures, followed by Enterobacter spp., which comprised 28.6% (4/14) of the isolates. Klebsiella pneumoniae and Escherichia coli were each identified as a single isolate, representing 7.1% (1/14) of the positive cultures (Figure 4B).
Antibiotic susceptibility of isolates: the isolates showed the highest sensitivity to ciprofloxacin, with 100% sensitivity observed for Enterobacter spp., E. coli and K. pneumoniae spp., whereas S. aureus exhibited 75% sensitivity. Clindamycin, on the other hand, performed best against S. aureus (100% sensitivity), while K. pneumoniae displayed 75% sensitivity. Importantly, none of the isolates tested in this study were sensitive to the WHO-recommended first-line antibiotics for CAP (penicillin and cephalosporins) (Table 2).
Clinical and laboratory predictors for positive blood culture results: multivariate logistic regression analysis revealed that fever (>38.5°C), oxygen saturation (<90%), the need for oxygen therapy, a high respiratory rate (>60 cycles/minute), and leucocytosis (>15,000 cells/μl) were strongly associated with bacteremia among children with CAP ((AOR 5.7 57) P=0.005), (AOR 2.7 95%CI [1.05 - 72.25] P = 0.015), (AOR 2.1 95%CI [1.41 - 7.676] P=0.022), (AOR 6.7 95%CI [2.018 - 22.47] P=0.002) and (AOR 8.895% CI [1.387 - 31.112] P=0.004) respectively) (Table 3).
Our study investigated the magnitude and factors associated with bacteremia among children under five years of age diagnosed with CAP. We found a prevalence of bacteremia of 7.2% which was lower than that reported elsewhere in African countries [12-15]. The low prevalence of bacteremia in this setting may be partly due to the introduction and wide coverage of pneumococcal conjugate and H. influenzae type B vaccines, incidences of viral pneumonia, or the unreported use of antibiotics prior to obtaining blood cultures [16].
We observed a predominance of S. aureus among the isolates from positive blood cultures, which is comparable to findings from previous studies [13,17]. Trends and proportions of CAP etiology differ, largely owing to vaccination coverage. In Tanzania, for example, where diphtheria, tetanus, pertussis, hepatitis-b, and hib (DTP-HepB-Hib) and Pneumococcal Conjugate Vaccine (PCV) coverage is more than 80% [18,19]. The principal cause of CAP (H. influenzae type b and pneumococcus) is expected to be relatively controlled through immunization. Moreover, the distribution among other known CAP aetiologies could be multifactorial [20-22]. Our findings suggest that bacterial species not targeted by current vaccines may dominate the CAP etiology, highlighting the need for continued surveillance and potential adjustments to vaccine strategies.
Of concern, the isolates were insensitive to amoxicillin and cephalosporin, WHO recommended as first-line treatment for CAP in children. Our findings are in line with the emergence of antimicrobial drug resistance, particularly among isolates linked to CAP [23,24]. Owing to the challenges in accurately diagnosing and identifying the etiology of CAP, the WHO recommends empirical treatment for CAP in children [7]. This approach, along with prevalent antibiotic use malpractices, may have significantly contributed to the emergence of multidrug-resistant isolates associated with CAP in children.
We found that a positive blood culture could be predicted by fever, oxygen saturation, the need for oxygen therapy, a high respiratory rate, and leukocytosis. These clinical parameters would not be pathophysiologic signatures specific for blood culture positivity but rather have been associated with childhood pneumonia [25-28]. On the other hand, for instance, an increased number of WBCs is generally indicative of infection. In our study, leukocytosis (WBC >15,000/μl) was strongly associated with positive blood cultures, which is also consistent with findings from other studies [29,30]. Notably, neither age nor nutritional status of participants was associated with bacteraemia.
Study limitation: our study was limited to conventional blood culture, which may have been associated with inherent low sensitivity for isolate detection. Thus, we might have been unable to capture the entire spectrum of bacteremia among children with CAP, especially the attribution of fastidious microorganisms. Furthermore, the cross-sectional design of the study did not allow for follow-up of participants, thereby limiting our ability to assess outcomes such as the duration of hospitalization or compare lengths of stay between children with and without bacteraemia. These limitations should be considered when interpreting the findings and highlight areas for further investigation.
Taken together, our study revealed a predominance of S. aureus among positive blood cultures among children clinically diagnosed with CAP, whereas the majority of isolates exhibited relative resistance to antimicrobials, which are the WHO-recommended first-line treatments. These findings underscore the need for routine culture and susceptibility tests for effective CAP treatment and curbing the increasing burden of antimicrobial resistance.
What is known about this topic
- Community-acquired pneumonia contributes a significant proportion of deaths among children under five in lower-middle-income countries, including Tanzania;
- There is a rising trend of MDR in bacterial isolates associated with CAP.
What this study adds
- This study provides new insights into the distribution of bacterial isolates associated with bacteremia in children with CAP in our settings, highlighting the predominance of S. aureus species;
- We are reporting high resistance rates to WHO-recommended first-line antibiotics for pediatric CAP;
- The study highlights to key clinical predictors of bacteremia in children with CAP in the study settings being fever, oxygen saturation, the need for oxygen therapy, a high respiratory rate, and leucocytosis.
The authors declare no competing interests.
Rehema Tagalile, Fransisca Kimaro, and Dina Mahamba conceived, designed, and executed the study; Rehema Tagalile collected the data and samples; Rehema Tagalile, Fransisca Kimaro, Dina Mahamba, and Emmanuel Nkuwi performed the formal analysis; Rehema Tagalile and Emmanuel Nkuwi wrote the manuscript, which was critically reviewed by all the authors. All the authors read and approved the final version of this manuscript.
The authors extend their gratitude to all the children and caregivers who participated in this study, staff from Dodoma Regional Referral Hospital for their cooperation during the study, and the University of Dodoma for providing financial support.
Table 1: sociodemographic characteristics of the parents or guardians and their 195 children diagnosed with CAP in Dodoma, Central Tanzania, from October 2018 to March 2019
Table 2: antibiotic sensitivity of the 15 bacterial isolates from 195 children diagnosed with CAP in Dodoma, Central Tanzania, from October 2018 to March 2019
Table 3: factors associated with positive blood cultures among 195 children diagnosed with CAP in Dodoma, Central Tanzania, from October 2018 to March 2019
Figure 1: enrolment process of the 195 children diagnosed with CAP in Dodoma, Central Tanzania, from October 2018 to March 2019
Figure 2: nutritional and vaccination status of 195 children diagnosed with CAP in Dodoma Region, Central Tanzania, from October 2018 to March 2019
Figure 3: clinical characteristics of 195 children diagnosed with CAP in Dodoma, Central Tanzania, from October 2018 to March 2019
Figure 4: blood culture results (A) and distribution of bacterial isolates (B) detected in the blood samples obtained from 195 children diagnosed with CAP in Dodoma, Central Tanzania, from October 2018 to March 2019
- Davies HD. Community-acquired pneumonia in children. Paediatr Child Health. 2003 Dec;8(10):616-9. PubMed | Google Scholar
- Nair H, Simões EA, Rudan I, Gessner BD, Azziz-Baumgartner E, Zhang JSF et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet. 2013 Apr 20;381(9875):1380-1390. PubMed | Google Scholar
- Ning G, Wang X, Wu D, Yin Z, Li Y, Wang H et al. The etiology of community-acquired pneumonia among children under 5 years of age in mainland China, 2001-2015: A systematic review. Hum Vaccin Immunother. 2017 Nov 2;13(11):2742-2750. PubMed | Google Scholar
- Meyer Sauteur PM. Childhood community-acquired pneumonia. Eur J Pediatr. 2024 Mar;183(3):1129-1136. PubMed | Google Scholar
- Ngocho JS, Horumpende PG, de Jonge MI, Mmbaga BT. Inappropriate treatment of community-acquired pneumonia among children under five years of age in Tanzania. Int J Infect Dis. 2020 Apr;93:56-61. PubMed | Google Scholar
- Rudan I, O'Brien KL, Nair H, Liu L, Theodoratou E, Qazi S et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013 Jun;3(1):010401. PubMed | Google Scholar
- World Health Organization. WHO Recommendations on the Management of Diarrhoea and Pneumonia in HIV-Infected Infants and Children: Integrated Management of Childhood Illness (IMCI). 2010. PubMed | Google Scholar
- Chiang WC, Teoh OH, Chong CY, Goh A, Tang JP, Chay OM. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology. 2007 Mar;12(2):254-61. PubMed | Google Scholar
- Ministry of Health, Community Development, Gender, Elderly and Children, Tanzania. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland. 2021.
- Fund C, World Health Organization. WHO child growth standards and the identification of severe acute malnutrition in infants and children. 2009. Google Scholar
- Mori R, Lakhanpaul M, Verrier-Jones K. Diagnosis and management of urinary tract infection in children: summary of NICE guidance. BMJ. 2007 Aug 25;335(7616):395-7. PubMed | Google Scholar
- Sigaúque B, Roca A, Bassat Q, Morais L, Quintó L, Berenguera A et al. Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors. J Trop Pediatr. 2009 Dec;55(6):379-87. PubMed | Google Scholar
- Nantanda R, Hildenwall H, Peterson S, Kaddu-Mulindwa D, Kalyesubula I, Tumwine JK. Bacterial aetiology and outcome in children with severe pneumonia in Uganda. Ann Trop Paediatr. 2008 Dec;28(4):253-60. PubMed | Google Scholar
- Schwarz NG, Sarpong N, Hünger F, Marks F, Acquah SEK, Agyekum A et al. Systemic bacteraemia in children presenting with clinical pneumonia and the impact of non-typhoid salmonella (NTS). BMC Infect Dis. 2010 Nov 4:10:319. PubMed | Google Scholar
- Johnson AW, Osinusi K, Aderele WI, Gbadero DA, Olaleye OD, Adeyemi-Doro FA. Etiologic agents and outcome determinants of community-acquired pneumonia in urban children: A hospital-based study. J Natl Med Assoc. 2008 Apr;100(4):370-85. PubMed | Google Scholar
- Fritz CQ, Edwards KM, Self WH, Grijalva CG, Zhu Y, Arnold SR et al. Prevalence, Risk Factors, and Outcomes of Bacteremic Pneumonia in Children. Pediatrics. 2019 Jul;144(1):e20183090. PubMed | Google Scholar
- Negash AA, Asrat D, Abebe W, Hailemariam T, Hailu T, Aseffa A et al. Bacteremic Community-Acquired Pneumonia in Ethiopian Children: Etiology, Antibiotic Resistance, Risk Factors, and Clinical Outcome. Open Forum Infect Dis. 2019 Jan 23;6(3):ofz029. PubMed | Google Scholar
- Sangeda RZ, James D, Mariki H, Mbwambo ME, Mwenesi ME, Nyaki H et al. Childhood vaccination trends during 2019 to 2022 in Tanzania and the impact of the COVID-19 pandemic. Hum Vaccin Immunother. 2024 Dec 31;20(1):2356342. PubMed | Google Scholar
- Mutagonda RF, Bwire G, Sangeda RZ, Kilonzi M, Mlyuka H, Ndunguru J et al. Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania. Infect Drug Resist. 2022 Aug 10;15:4407-4418. PubMed | Google Scholar
- Shah SS, Dugan MH, Bell LM, Grundmeier RW, Florin TA, Hines EM et al. Blood cultures in the emergency department evaluation of childhood pneumonia. Pediatr Infect Dis J. 2011 Jun;30(6):475-9. PubMed | Google Scholar
- Heine D, Cochran C, Moore M, Titus MO, Andrews AL. The prevalence of bacteremia in pediatric patients with community-acquired pneumonia: guidelines to reduce the frequency of obtaining blood cultures. Hosp Pediatr. 2013 Apr;3(2):92-6. PubMed | Google Scholar
- Owais A, Tikmani SS, Sultana S, Zaman U, Ahmed I, Allana S et al. Incidence of pneumonia, bacteremia, and invasive pneumococcal disease in Pakistani children. Trop Med Int Health. 2010 Sep;15(9):1029-36. PubMed | Google Scholar
- Ishimwe E, Rogo T. Antibiotic resistance in children with bacteremia admitted in the largest tertiary hospital in rwanda. Rwanda Med J. 2018;75(2):5-8.
- Mahende C, Ngasala B, Lusingu J, Butichi A, Lushino P, Lemnge M et al. Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania. BMC Res Notes. 2015 Jul 3;8:289. PubMed | Google Scholar
- Yadav KK, Awasthi S. Childhood Pneumonia: What's Unchanged, and What's New? Indian J Pediatr. 2023 Jul;90(7):693-699. PubMed | Google Scholar
- Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol. 2007 Jan;20(1):108-19. PubMed | Google Scholar
- Sacco K, Castagnoli R, Vakkilainen S, Liu C, Delmonte OM, Oguz C et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med. 2022 May;28(5):1050-1062. PubMed | Google Scholar
- Chen Y, Li L, Wang C, Zhang Y, Zhou Y. Necrotizing Pneumonia in Children: Early Recognition and Management. J Clin Med. 2023 Mar 14;12(6):2256. PubMed | Google Scholar
- Hickey RW, Bowman MJ, Smith GA. Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department. Ann Emerg Med. 1996 Jun;27(6):721-5. PubMed | Google Scholar
- Resti M, Moriondo M, Cortimiglia M, Indolfi G, Canessa C, Becciolini L et al. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis. 2010 Nov 1;51(9):1042-9. PubMed | Google Scholar
Search
This article authors
On Pubmed
On Google Scholar
Citation [Download]
Navigate this article
Similar articles in
Key words
Tables and figures
Article metrics
Map loading delayed...







